Stocks
Health Care
bio
BioRad Laboratories
NYSE: BIO
+0.81 (+0.31%)
262.63
USD
At close at Mar 13, 20:38 UTC
Income Statement
Revenue
2.57B
Gross Profit
1.38B
Operating Income
268.90M
Pretax Income
995.50M
Net Income
-1.84B
EBITDA
-2.29B
EBIT
-2.29B
Earnings Per Share
-64.9
Balance Sheet
Cash & Cash Equivalents
434.67M
Total Debt
1.39B
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
7.47B
Book Value Per Share
264.7
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.